Bayer Seeks to Boost China Ties and Innovation Through New Investments and Partnerships
-
Bayer plans to invest more in China and build bridges to overcome global challenges, acknowledging China's progress in innovation.
-
Bayer notes China's improvements in areas like new drug approvals and reimbursement list expansion, increasing life expectancy.
-
Bayer says CIIE promotes exchange of products and ideas between China and the world, boosting innovation and partnerships.
-
Experts say major global challenges like climate, food, and healthcare require cross-country collaboration.
-
Companies are proceeding cautiously amidst US rhetoric on decoupling from China.